Covered recipient · General Payments record
PUJA SINGH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,128.93
- Reported across 201 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $361.33 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $121.18 | 1 |
| ABBVIE INC. | $65.38 | 4 |
| Acerta Pharma LLC | $59.74 | 4 |
| Lilly USA, LLC | $37.38 | 2 |
| Novo Nordisk AS | $35.98 | 2 |
| Sumitomo Pharma America, Inc. | $22.32 | 1 |
| Amgen Inc. | $19.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.82 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106111666 | CMS |
| ABBVIE INC. | $16.62 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106111668 | CMS |
| ABBVIE INC. | $16.12 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106111670 | CMS |
| ABBVIE INC. | $17.82 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106111672 | CMS |
| Amgen Inc. | $19.35 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117685302 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.30 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104723459 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.73 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104753690 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.84 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104309280 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.87 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105549647 | CMS |
| GlaxoSmithKline, LLC. | $121.18 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116639762 | CMS |
| Lilly USA, LLC | $15.32 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135198470 | CMS |
| Lilly USA, LLC | $22.06 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135302856 | CMS |
| Novo Nordisk Inc | $15.48 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097147660 | CMS |
| Novo Nordisk Inc | $20.50 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096976052 | CMS |
| Sumitomo Pharma America, Inc. | $22.32 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148920867 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.